kb-gdt-01
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 7, 2023 (NCT06069570)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- T cellSupplementation
T cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06069570 | Phase 1 | Nov 7, 2023 | Kiromic BioPharma Inc., Statistics & Data Corporation, University of Pittsburgh |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kiromic BioPharma Inc. | For profit | 1 | 1 | 1 | 2023 |
| Statistics & Data Corporation | For profit | 1 | 0 | 1 | 2023 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1